NONOF:OTCMKTS
Novo Nordisk A/S
38,01 US$
arrow_downward
-0,88%(-0,34) 1D
30 სექ, 13:47:27 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NONOF...
Open
38,01 US$
High
38,41 US$
Low
37,91 US$
Mkt. cap
129,57 მლრ.
Avg. vol.
135,37 ათ.
Volume
8,53 ათ.
52-wk high
64,75 US$
52-wk low
34,00 US$
Beta
0,63
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
Open
38,01 US$
High
38,41 US$
Low
37,91 US$
Mkt. cap
129,57 მლრ.
Avg. vol.
135,37 ათ.
Volume
8,53 ათ.
52-wk high
64,75 US$
52-wk low
34,00 US$
Beta
0,63
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
Business North Carolina
·
1 საათის წინ
NC Trend: Novo Nordisk pilots a $150 million treatment plant in the Triangle.
The Motley Fool
·
3 საათის წინ
Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
Il Sole 24 ORE
·
4 საათის წინ
From AstraZeneca to Novo, investment in biotech continues
Stock Titan
·
5 საათის წინ
An experimental obesity drug changed brain responses to tempting foods and reduced cravings
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOმაზიარ მაიკ დუსტარ
Employees66,7 ათ.
Founded21 დეკ. 1923
HeadquartersBagsværd, დედაქალაქის რეგიონი, დანია
SectorPharmaceutical industry
Websitenovonordisk.com